These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1466 related items for PubMed ID: 27956794

  • 1. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
    Pejnovic N, Jeftic I, Jovicic N, Arsenijevic N, Lukic ML.
    World J Gastroenterol; 2016 Nov 28; 22(44):9706-9717. PubMed ID: 27956794
    [Abstract] [Full Text] [Related]

  • 2. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.
    Jeftic I, Jovicic N, Pantic J, Arsenijevic N, Lukic ML, Pejnovic N.
    Mol Med; 2015 May 22; 21(1):453-65. PubMed ID: 26018806
    [Abstract] [Full Text] [Related]

  • 3. IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis.
    Gao Y, Liu Y, Yang M, Guo X, Zhang M, Li H, Li J, Zhao J.
    Oncotarget; 2016 Jun 07; 7(23):33649-61. PubMed ID: 27172901
    [Abstract] [Full Text] [Related]

  • 4. Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.
    Vasseur P, Dion S, Filliol A, Genet V, Lucas-Clerc C, Jean-Philippe G, Silvain C, Lecron JC, Piquet-Pellorce C, Samson M.
    Oncotarget; 2017 Jul 25; 8(30):48563-48574. PubMed ID: 28611297
    [Abstract] [Full Text] [Related]

  • 5. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M.
    World J Gastroenterol; 2018 Jan 14; 24(2):179-194. PubMed ID: 29375204
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A.
    Adv Exp Med Biol; 2024 Jun 16; 1460():539-574. PubMed ID: 39287864
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis.
    Kim MB, Lee Y, Bae M, Kang H, Pham TX, Hu S, Lee JY, Park YK.
    J Nutr Biochem; 2020 Nov 16; 85():108463. PubMed ID: 32891893
    [Abstract] [Full Text] [Related]

  • 12. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C, Schönke M, Spoorenberg B, Lambooij JM, van der Zande HJP, Zhou E, Tushuizen ME, Andreasson AC, Park A, Oldham S, Uhrbom M, Ahlstedt I, Ikeda Y, Wallenius K, Peng XR, Guigas B, Boon MR, Wang Y, Rensen PCN.
    Elife; 2023 Jan 17; 12():. PubMed ID: 36648330
    [Abstract] [Full Text] [Related]

  • 13. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
    Kumar S, Verma AK, Rani R, Sharma A, Wang J, Shah SA, Behari J, Salazar Gonzalez R, Kohli R, Gandhi CR.
    Hepatology; 2020 Nov 17; 72(5):1586-1604. PubMed ID: 32031683
    [Abstract] [Full Text] [Related]

  • 14. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ, Libby AE, Bales ES, McMahan RH, Monks J, La Rosa FG, McManaman JL.
    J Physiol; 2019 Mar 17; 597(6):1565-1584. PubMed ID: 30536914
    [Abstract] [Full Text] [Related]

  • 15. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 16. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.
    Iacobini C, Menini S, Ricci C, Blasetti Fantauzzi C, Scipioni A, Salvi L, Cordone S, Delucchi F, Serino M, Federici M, Pricci F, Pugliese G.
    J Hepatol; 2011 May 18; 54(5):975-83. PubMed ID: 21145823
    [Abstract] [Full Text] [Related]

  • 17. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N, Zou A, Ghosh P, Ahamed F, Delker D, Zhang Y.
    J Biol Chem; 2020 Jan 24; 295(4):994-1008. PubMed ID: 31831621
    [Abstract] [Full Text] [Related]

  • 18. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP, Senthivinayagam S, Aljazi MB, Fader KA, Olenic SD, Brock JR, Lydic TA, Jones AD, Atshaves BP.
    Am J Physiol Gastrointest Liver Physiol; 2016 May 01; 310(9):G726-38. PubMed ID: 26968211
    [Abstract] [Full Text] [Related]

  • 19. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M, Csak T, Szabo G.
    World J Gastroenterol; 2014 Jul 14; 20(26):8525-34. PubMed ID: 25024607
    [Abstract] [Full Text] [Related]

  • 20. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
    Yamato M, Sakai Y, Mochida H, Kawaguchi K, Takamura M, Usui S, Seki A, Mizukoshi E, Yamashita T, Yamashita T, Ishida K, Nasti A, Tuyen HTB, Komura T, Yoshida K, Wada T, Honda M, Kaneko S.
    J Gastroenterol Hepatol; 2019 Aug 14; 34(8):1432-1440. PubMed ID: 30828861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.